Catalyst Wire Dossier Catalyst Wire Dossier

Artemether-lumefantrine dispersible tablet

artemether-lumefantrine · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Artemether-lumefantrine dispersible tablet, covering 2015-06-17 to 2015-06-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg [Phase 2, Phase 3]

See pricing